Preview Mode Links will not work in preview mode

Psychopharmacology and Psychiatry Updates

Feb 26, 2023

In this episode, we discuss an updated review of 11 studies that seek to evaluate the effect of antidepressants on the risk of hip and vertebral bone fractures. Although the overall effect size seems large, the absolute risk increase might be small.

Faculty: Jim Phelps, M.D.
Host: Richard Seeber, M.D.


Feb 21, 2023

Are antidepressants effective for managing explosive behavior? In this episode, we discuss the efficacy of antidepressants and mood stabilizers for managing explosive behavior, including some proposed doses of lithium and divalproex sodium, and the indications for using antidepressants.

Faculty: Carrie Vaudreuil,...


Feb 16, 2023

In this episode, we discuss a meta-analysis that included 6 million patients to assess whether pharmacotherapy increases the risk of substance use or misuse, specifically the risk of using stimulant medications in children with ADHD.

Faculty: David Rosenberg, M.D.
Host: Richard Seeber, M.D.


Feb 11, 2023

In this episode, we discuss the SGAs with the most evidence for explosive behavior, their side effects, and monitoring recommendations. We also address the reasons for considering other SGAs and clarify which FGA has the most evidence for aggression.

Faculty: Carrie Vaudreuil, M.D.
Host: Richard Seeber, M.D.


Feb 6, 2023

Should we start prescribing metformin to our patients on clozapine? In this episode, we discuss several articles on the efficacy of clozapine in preventing clozapine-induced weight gain, including some evidence on when metformin is more effective.

Faculty: Jim Phelps, M.D.
Host: Richard Seeber, M.D.